Login / Signup
Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction.
Andrew Tai
Andrew P Ambrosy
Marat Fudim
Published in:
European heart journal. Cardiovascular pharmacotherapy (2022)
Keyphrases
</>
ejection fraction
aortic stenosis
coronary artery disease
left ventricular